Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases.

Harry WangOmar DewidarSamuel L WhittleElizabeth GhogomuGlen HazlewoodKarin LederLawrence MbuagbawJordi Pardo PardoPhilip C Robinson Rachelle BuchbinderVivian Welch

Published in: Arthritis care & research (2022)

Sex and age were the most frequently considered PROGRESS-Plus factors in studies of COVID-19 vaccination in individuals with AIRDs. The generalizability of evidence to populations experiencing inequities is uncertain. Future COVID-19 vaccine studies should report participant characteristics in more detail to inform guideline recommendations.

Keyphrases

coronavirus disease
sars cov
case control
public health
clinical practice
drug induced